Breaking News
March 22, 2019 - Less invasive valve replacement can be safe and effective alternative for healthier patients
March 22, 2019 - Aphasia research reveals new, complex interactions between thought and language
March 22, 2019 - Artificial neural networks can predict how different areas in the brain respond to words
March 22, 2019 - Age-related changes to gut microbiome have adverse impact on vascular health, study shows
March 22, 2019 - Isolated seniors chat online to prevent cognitive decline
March 22, 2019 - Karyopharm Announces FDA Extension of Review Period for Selinexor New Drug Application
March 22, 2019 - Eruptive xanthomatosis
March 22, 2019 - Cause of vascular disease in kidney failure reversed in animal model
March 22, 2019 - Researchers discover possible new therapeutic strategy for pancreatic cancer
March 22, 2019 - Ebola spreads to second largest city in DRC
March 22, 2019 - Perivascular spaces contribute to worse cognitive health in older adults
March 22, 2019 - Adolescent daily users more likely to obtain electronic cigarettes from commercial sources
March 22, 2019 - FDA Approves Genentech’s Tecentriq in Combination With Chemotherapy for the Initial Treatment of Adults With Extensive-Stage Small Cell Lung Cancer
March 22, 2019 - Diabetes myths and facts: MedlinePlus Medical Encyclopedia
March 22, 2019 - TGen and ABL pursue global rollout of advanced TB test
March 22, 2019 - Traffic light labels influence people to choose healthier and more sustainable meals
March 22, 2019 - Alzheimer’s patients using antiepileptic drugs have twice the risk of pneumonia, study shows
March 22, 2019 - Skin diseases may be more prevalent than previously thought
March 22, 2019 - Overall rates of death from breast cancer are falling across the EU
March 22, 2019 - Novel plasmid could hold key to control of mosquito-borne illness
March 22, 2019 - Female Emergency Physicians Paid Less Than Males
March 22, 2019 - Estimated average glucose (eAG): MedlinePlus Medical Encyclopedia
March 22, 2019 - Experimental drug could be new option for type 2 diabetes
March 22, 2019 - Five Things To Know About The Electronic Health Records Mess
March 22, 2019 - TMJ disorders could be treated with tissue-engineered implants after successful animal study
March 22, 2019 - Team-based approach is key to successful care of pregnant women with heart failure
March 22, 2019 - Study identifies gene variant associated with accelerated cellular aging
March 21, 2019 - Salk scientists show how background noise from neurons can interrupt focused attention
March 21, 2019 - New class of drugs could help treat patients diagnosed with ovarian cancer
March 21, 2019 - Tecentriq Approved for Small Cell Lung Cancer
March 21, 2019 - Adipocyte glucocorticoid receptors play a role in developing steroid diabetes
March 21, 2019 - Climate change can affect nutrient content of crops, harming human health
March 21, 2019 - Podcast: KHN’s ‘What The Health’ Surprise! Fixing Surprise Medical Bills Is Harder Than it Looks
March 21, 2019 - Chemistry researchers patent new method for making anti-leukemia compounds
March 21, 2019 - UIC scientists identify hidden proteins in bacteria
March 21, 2019 - New Australian drug trial achieves remarkable results in patients with acute myeloid leukemia
March 21, 2019 - Females live longer when they have help raising offspring
March 21, 2019 - How did orthodontists sell orthodontics?
March 21, 2019 - In the Spotlight: From dietitian to physician assistant student
March 21, 2019 - The CRISPR Revolution: What You Need to Know
March 21, 2019 - FDA Chief Calls For Stricter Scrutiny Of Electronic Health Records
March 21, 2019 - Combined glucocorticoid and antioxidant therapy could benefit premature babies
March 21, 2019 - Low levels of certain eye proteins could serve as predictor for Alzheimer’s
March 21, 2019 - Post-traumatic holocaust survivors transmit negative views on aging to offspring
March 21, 2019 - City of Hope receives $7.5 million in grant awards to study cutaneous T cell lymphoma
March 21, 2019 - New video game-led training device helps stroke survivors regain arm mobility
March 21, 2019 - Compounds in coffee could slow prostate cancer growth
March 21, 2019 - New mobile DNA element in Wolbachia may contribute to improved disease control strategies
March 21, 2019 - Phase 2 Clinical Trial of Bermekimab Shows Potential New Standard of Care for Treatment of Hidradenitis Suppurativa, Including Significant Pain Reduction without Antibiotics
March 21, 2019 - More than one-third of patients risk major bleeding by doubling up on blood thinners
March 21, 2019 - A skeptical look at popular diets: Thumbs up for Mediterranean
March 21, 2019 - PTSD After Cardiac Arrest Predicts More Heart Trouble
March 21, 2019 - Role of immunological imprinting in elicitation of new antibodies
March 21, 2019 - Breast cancer relapse predictor tool may soon be a reality
March 21, 2019 - New computer program developed by TGen lights up cancer-causing genetic mutations
March 21, 2019 - FDA warns two breast implant makers for failure to comply with post-approval study requirements
March 21, 2019 - Butler Hospital receives COBRE grant to enhance research on neuropsychiatric illnesses
March 21, 2019 - Majority of osteoporosis clinical practice guidelines ignore patients’ voices
March 21, 2019 - Generic messages don’t help patients to lose weight
March 21, 2019 - Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia
March 21, 2019 - Two-drug combos using popular calcium channel blocker show superiority in lowering BP
March 21, 2019 - Q BioMed and Mannin Research collaborate with McMaster University to develop GDF15 biomarker glaucoma diagnostic kit
March 21, 2019 - First-in-human pilot study shows positive results for ‘bacteria-phobic’ catheter
March 21, 2019 - Itamar Medical launches next-generation WatchPAT system for home sleep apnea testing
March 21, 2019 - Study estimates health and economic impacts of healthy food prescriptions
March 21, 2019 - Detecting fungal disease in crops with multispectral imaging system
March 21, 2019 - MIT announces creation of the Alana Down Syndrome Center
March 21, 2019 - Next-generation LVAD device clinically superior, safer for heart failure patients
March 21, 2019 - Allergan Announces FDA Approval of Avycaz (ceftazidime and avibactam) for Pediatric Patients
March 21, 2019 - Mutations in noncoding genes could play big role in regulating cancer, study finds
March 21, 2019 - A medical student’s thoughts on Match Day
March 21, 2019 - Are eggs good or bad for you?
March 21, 2019 - New analysis reveals precision oncology insights for colorectal cancer
March 21, 2019 - Pollutants appear to weaken immune system and increase pathogen virulence
March 21, 2019 - Researchers develop and validate scale for rating severity of mononucleosis
March 21, 2019 - Scientists identify generation of key immune response in mice on introducing solid food
March 21, 2019 - New nanomaterial could restore internal structure of damaged bones
March 21, 2019 - Selective destruction of prostate tumor as effective as complete prostate removal
March 21, 2019 - 2011 to 2015 Saw Increase in Psychiatric ED Visits for Youth
March 21, 2019 - Tapeworm drug targets common vulnerability in tumor cells
NJIT team wins two major international awards for vision therapy platform

NJIT team wins two major international awards for vision therapy platform

image_pdfDownload PDFimage_print

An NJIT-led team of engineers, game designers, artists and clinicians won two major international awards for its vision therapy platform, including “most innovative breakthrough,” at the 2018 Augmented World Expo Europe (AWE EU), the leading industry conference for augmented reality technology.

The competition pitted NJIT against 114 teams from design programs at MIT, Caltech, NASA and other leaders in the field. Sponsors of the award, announced in Munich before hundreds of designers, CEOs and investors from the sector, also include the global engineering organization IEEE and VR First, the virtual reality educational outreach organization.

“We are thrilled to win the Auggie Innovation Award – and to be here at all. Conferences such as AWE EU are a critical meeting ground for industry and academia, serving as a catalyst that can lead to breakthroughs that change our society,” said Tara Alvarez, professor of biomedical engineering at NJIT and the team’s leader. “So much great science exists within our labs, but it can be a challenge to translate those ideas into broader societal impacts.”

Alvarez, the lone woman standing on the confetti-strewn stage, also won the “Woman Laureate” award, which recognizes project leadership skills.

The NJIT project, VERVE (Virtual Eye Rotation Vision Exercises), employs virtual reality games to correct an eye motor disorder called convergence insufficiency, in which the muscles that control eye movements do not coordinate to focus on near objects. Because each eye sees images separately, the person experiences double and blurred vision, headaches and difficulty concentrating. The impact on cognition and learning can be severe, particularly in children.

The device, which has potential as a biomarker for concussion, is being tested in children’s hospitals across the country, and Alvarez and her alumni NJIT students have started a company, OculoMotor Technologies, to commercialize it. Alvarez is the company’s chief scientific officer, Mitchell Scheiman, O.D., Ph.D., of Salus University, is the chief clinical officer and John Vito d’Antonio-Bertagnolli ’16 H MS ’17 and Chang Yaramothu,’13 MS ’14 Ph.D. ’17 are CEO and chief technology officer, respectively. Their collaborators and backers include Salus University, Children’s Hospital of Philadelphia, New Jersey Health Foundation and the National Science Foundation.

“These therapies have not evolved much since the 70s, and while they’re very good, they’re incredibly boring,” noted Alvarez, founder of NJIT’s Vision and Neural Engineering Laboratory. “We hope to address that by creating virtual reality games that are going to be done correctly because of the equipment, and they’ll be fun so people want to do them.”

AWE EU shared the meeting space in Munich with IEEE’s annual ISMAR (International Symposium of Mixed and Augmented Reality) conference, billed as the leading international academic conference in the fields of augmented reality and mixed reality. The expo floor featured flashy demos from big companies like Bosch, as well as an expansive “startup alley” showcasing new projects.

“We met so many people from all over the world, and everyone was an expert in their own way. To be recognized and awarded out of such a talented group of people is very meaningful for a small resource-strapped startup like our own,” noted d’Antonio-Bertagnolli, who accompanied Alvarez. “This was such an incredible experience, from start to finish. The NJIT community really came together to support our team and our project, so I would have been happy as a finalist even if we didn’t win. But to come away with two awards, one to our company, and one to Tara, was just the icing on the cake.”

Indeed, the campus-based site of the National Science Foundation’s I-Corps program was an early supporter of the project and the team went on to win a $50,000 grant from the national program. Alvarez called I-Corps, along with the Center for Translation of Rehabilitation Engineering Advances and Technology, critical in teaching scientists how to become entrepreneurs and to “move science forward.”

“The Auggie Awards are a validation of the tremendous progress the team has made in melding skills from multiple disciplines – engineering, information technology, digital design – to address critical vision disorders using AR/VR technology,” noted Judith Sheft, associate vice president for technology development at NJIT and co-principal investigator of the campus-based I-Corps program, who has worked with the team to incorporate customer insights into its device and to develop a robust business model to deploy it.

The team’s diagnostic machine integrates two devices – a functional near-infrared spectroscopy (fNIRS) imaging machine and a video-based eye-tracking system – that together detect how changes in brain activity following an injury, including a mild concussion, correspond with changes in eye movements. Strapped to the head, the fNIRS machine uses light beams to measure blood oxygen levels – indicators of neural activity – in different regions of the brain. An ocular device Alvarez has created, known as a Vision and Neural Assessment Equipment system, measures eye movements and accommodation – the ability to see images clearly, which are promising biomarkers for neurological functions such as visual attention and memory.

The goal is to create a portable medical device that can be carried to sports arenas to measure the severity of a brain injury on the spot, helping the coach and team doctor determine whether an athlete is at risk if sent back into the game. Repeated injuries exacerbate neurological problems down the road.

“The visual neural circuit composes a lot of space in the brain, and is thus easily damaged by a concussion,” explained Alvarez. “In terms of cognitive load, if someone is expending significantly more energy acquiring visual information, then less energy is available for thinking.”

Alvarez said she savored the “Woman Laureate” award, because it gave her the chance to thank her “most impactful teachers – my kids.”

“My son, Christian, has taught me the importance of play, and my daughter, Ari, has showed me how to be more compassionate towards others. These lessons are deeply integrated in the philosophy with which I lead my lab and the way John, Chang, Mitch and I lead our company, OculoMotor Technologies,” she said.

Source:

http://news.njit.edu/njit-team-takes-two-awards

Tagged with:

About author

Related Articles